Form 4: Health Catalyst GC Executes Sell-to-Cover Transaction

General Counsel Benjamin Landry disposed of 13,779 shares of Health Catalyst, Inc. to satisfy tax withholding obligations.

Summary

• Benjamin Landry, General Counsel of Health Catalyst, Inc., disposed of 13,779 shares of common stock.
• The transaction occurred on June 1, 2026, at a price of $1.3702 per share.
• Following this transaction, the reporting person retains beneficial ownership of 364,539 shares.
• The disposal was a mandatory 'sell-to-cover' transaction to satisfy tax withholding requirements related to the vesting of Restricted Stock Units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a mandatory administrative action rather than a discretionary market move.

Positives

• The transaction was non-discretionary and mandated by the company's equity incentive plan policies.

Negatives

• The transaction reflects a reduction in the direct equity stake held by a key executive.

Risks

• None identified; this is a routine administrative tax-related transaction.

Future Outlook

Not applicable as this is a routine insider transaction report.

Industry Context

StockSavvy.ai notes that sell-to-cover transactions are standard corporate governance practices for executives receiving equity-based compensation and do not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction aligns with standard industry practices for handling tax liabilities associated with RSU vesting.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was non-discretionary.

Key Dates

Keywords

Health Catalyst, HCAT, Insider Trading, Form 4, Equity Compensation, Tax Withholding